| 1 |
34393062 | Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer. | 2022 Mar |
1 |
| 2 |
34922916 | Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. | 2022 Jan 18 |
2 |
| 3 |
35064653 | Dynamic Adjust of Non-Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR-II Imaging Mediated Photothermal Therapy and Immunotherapy. | 2022 Mar |
1 |
| 4 |
35078640 | Downregulation of CD73 on CD4+ T cells from patients with chronic Chikungunya infection. | 2022 Apr |
2 |
| 5 |
35091759 | Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients. | 2022 Apr |
1 |
| 6 |
35199627 | Variability in CD39 and CD73 protein levels in uveal melanoma patients. | 2022 Feb 24 |
1 |
| 7 |
35218567 | Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells. | 2022 Apr |
2 |
| 8 |
35222389 | CD39/CD73 Dysregulation of Adenosine Metabolism Increases Decidual Natural Killer Cell Cytotoxicity: Implications in Unexplained Recurrent Spontaneous Abortion. | 2022 |
3 |
| 9 |
35325005 | Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals. | 2022 Mar |
1 |
| 10 |
35327609 | Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. | 2022 Mar 8 |
1 |
| 11 |
35371066 | Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant. | 2022 |
1 |
| 12 |
35443187 | Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. | 2022 Apr 19 |
1 |
| 13 |
35471483 | Burnstock oration - purinergic signalling in kidney transplantation. | 2022 Apr 26 |
1 |
| 14 |
35508221 | Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment. | 2022 May 4 |
1 |
| 15 |
35550530 | CD39 - A bright target for cancer immunotherapy. | 2022 Jul |
3 |
| 16 |
32203145 | Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function. | 2021 Jan |
3 |
| 17 |
32648591 | The role of the CD39-CD73-adenosine pathway in liver disease. | 2021 Feb |
6 |
| 18 |
32663496 | Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis. | 2021 Jan |
1 |
| 19 |
32961376 | Paradoxical Regulation of Allogeneic Bone Marrow Engraftment and Immune Privilege by Mesenchymal Cells and Adenosine. | 2021 Jan |
1 |
| 20 |
33098857 | B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy. | 2021 Jan 8 |
1 |
| 21 |
33123998 | Adenosine Signaling in the Tumor Microenvironment. | 2021 |
1 |
| 22 |
33161021 | Extracellular adenosine 5'-triphosphate in pulmonary disorders. | 2021 May |
2 |
| 23 |
33222670 | Targeting Tumor-derived Exosomes Expressing CD73: New Opportunities in the Pathogenesis and Treatment of Cancer. | 2021 |
2 |
| 24 |
33340515 | Adenosine metabolism in the vascular system. | 2021 May |
5 |
| 25 |
33416945 | Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival. | 2021 Jul |
1 |
| 26 |
33460629 | Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut. | 2021 May |
2 |
| 27 |
33482152 | Extracellular purines and bone homeostasis. | 2021 May |
2 |
| 28 |
33524787 | Diabetes and hypertension: Pivotal involvement of purinergic signaling. | 2021 May |
1 |
| 29 |
33564128 | Modulatory activity of adenosine on the immune response in cord and adult blood. | 2021 Nov |
1 |
| 30 |
33610376 | Targeting adenosine and regulatory T cells in cancer immunotherapy. | 2021 Apr |
2 |
| 31 |
33708212 | Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma. | 2021 |
1 |
| 32 |
33740184 | Possible role of purinergic signaling in COVID-19. | 2021 Aug |
1 |
| 33 |
33747526 | Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B. | 2021 Jan |
4 |
| 34 |
33761054 | Antenatal Dexamethasone Treatment Induces Sex-dependent Upregulation of NTPDase1/CD39 and Ecto-5'-nucleotidase/CD73 in the Rat Fetal Brain. | 2021 Mar 24 |
1 |
| 35 |
33848530 | ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma. | 2021 Oct |
3 |
| 36 |
33913070 | Neutrophils: fast and furious-the nucleotide pathway. | 2021 Sep |
3 |
| 37 |
33993290 | Testicular adenosine acts as a pro-inflammatory molecule: role of testicular peritubular cells. | 2021 Jul 1 |
1 |
| 38 |
34089473 | AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments. | 2021 Oct |
1 |
| 39 |
34105986 | Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation. | 2021 Aug 1 |
1 |
| 40 |
34159634 | Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism. | 2021 Jul |
3 |
| 41 |
34177939 | Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways. | 2021 |
1 |
| 42 |
34265363 | Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. | 2021 Oct 1 |
2 |
| 43 |
34356618 | Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease. | 2021 Jul 6 |
2 |
| 44 |
34360833 | CD39 Regulation and Functions in T Cells. | 2021 Jul 28 |
4 |
| 45 |
34381563 | High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer. | 2021 Aug 3 |
1 |
| 46 |
34442398 | Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells. | 2021 Jul 30 |
1 |
| 47 |
34571872 | Thrombo-Inflammation: A Focus on NTPDase1/CD39. | 2021 Aug 27 |
3 |
| 48 |
34625545 | CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. | 2021 Oct 8 |
1 |
| 49 |
34650224 | Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73. | 2021 Oct 14 |
1 |
| 50 |
34675608 | Association of the ENPP1/ENTPD1 Polymorphisms in Hemodialysis Patients. | 2021 |
1 |